Cargando…

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems

Cancer is one of the main causes of disease-related deaths in the world. Although cancer treatment strategies have been improved in recent years, the survival time of cancer patients is still far from satisfied. Cancer immunotherapy, such as Oncolytic virotherapy, Immune checkpoints inhibition, Chim...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Luyao, Chen, Yurong, Liu, Xinrui, Li, Ziyi, Dai, Xiangpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801488/
https://www.ncbi.nlm.nih.gov/pubmed/35111663
http://dx.doi.org/10.3389/fonc.2021.704999